The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase (Q33358304)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase |
scientific article |
Statements
1 reference
The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase (English)
1 reference
Hagop M Kantarjian
1 reference
Stefan Faderl
1 reference
William Wierda
1 reference
Susan O'Brien
1 reference
Mary Beth Rios
1 reference
Francis Giles
1 reference
Jorge E Cortes
1 reference
Moshe Talpaz
1 reference
Debra Resta
1 reference
Thomas B Sneed
1 reference
B Nebiyou Bekele
1 reference
Xian Zhou
1 reference
1 January 2004
1 reference
1 reference
100
1 reference
116-121
1 reference
Identifiers
1 reference
1 reference